Tag: arteriovenous fistula
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
VasQ: The next standard-of-care innovation
This advertorial is sponsored by Laminate Medical Technologies.
At the 2024 Charing Cross (CX) International Symposium (April 23–25) in London, England, the Vascular Access Masterclass...
Vascular external support system use found to boost key functional outcomes...
Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the...
VasQ AVF creation device receives FDA clearance
Laminate Medical Technologies has announced their flagship device, the VasQ external vascular support, has been cleared by the Food and Drug Administration (FDA) for...
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS,...
Amplifi vein dilation system continues to show promise following latest first-in-human...
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of...
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular...
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to...
Intraoperative vascular mapping during hemodialysis access ‘should be incorporated into routine...
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin, MD, associate professor of surgery...
VentureMed completes enrollment of Flex Vessel Prep system randomized controlled trial...
VentureMed Group recently announced that it has completed enrollment of a randomized controlled trial (RCT) entitled "Flex Vessel Prep prior to PTA for the...
Amplifi vein dilation system demonstrates ‘encouraging’ clinical results in hemodialysis access
Artio Medical announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium (Nov....
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Fist Assist device achieves significant perforator vein dilation for improved endoAVF...
Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial (FACT...
#SVSTweetChat hits high levels of engagement
Since the inaugural #SVSTweetChat that covered early career advice went live on Twitter in April, the monthly social media initiative has proven to be...
Risk of ‘feared’ ischemic steal syndrome comparable for tapered and non-tapered...
In a recent systematic review and meta-analysis, Venkata Sai Jasty, from the University of Arizona College of Medicine in Tuscon, Arizona, and colleagues found...
Ultrasound-guided PTA is a ‘valuable tool’ in vascular access stenosis
Routine ultrasound-guided percutaneous transluminal angioplasty (PTA) is a feasible treatment for native arteriovenous fistula (AVF) dysfunction, according to a recent study by Antonio Granata,...